Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
By A. Perner, N. Haase, A. Guttormsen, J. Tenhunen, G. Klemenzson, A. Åneman, K. R. Madsen, M. Møller, Jeanie M Elkjær, Lone M. Poulsen and 22 more. New England Journal of Medicine, 2012
1,536 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/22640861d71d91b8948806651def64f5d8adda1d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Sepsis and septic shock. (2018, background): “52 56 Thus, given the increased expense associated with use of colloid fluids and the increased risk of nephrotoxicity (except with albumin, which does not increase this risk), 55 initial resuscitation should use crystalloid fluids.”
- KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. (2013, background): “In addition, we noted that there appears to be harm with starch-containing fluids.(32-36) Therefore, these solutions should be avoided in patients at risk of AKI or with AKI.”
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (2013, unknown): “(This recommendation is based on the results of the VISEP [128], CRYSTMAS [122], 6S [123], and CHEST [124] trials.”
- Systemic inflammatory response syndrome criteria in defining severe sepsis. (2015, methodology): “APACHE III was developed in 1991 [5] and was validated and further updated in 1998 [6].”
- IAP/APA evidence-based guidelines for the management of acute pancreatitis. (2013, background): “The use of hydroxyethyl starch (HES) is discouraged since it increased the rates of renal failure and mortality, as compared to Ringer’s lactate in a multicenter RCT in patients with severe sepsis in an intensive care [32].”